| 2026-01-08 | Dr. William ChouPresident, CEO & Director | 5,92k | 0,00 | Derivative Exercise and Retained Stock | - | 6,52k | 987,33% |
| 2026-01-08 | Dr. William ChouPresident, CEO & Director | -4,08k | 75,16k | Derivative Exercise and Sale | 18,44 | 6,52k | - |
| 2026-01-08 | Ms. Kathleen BorthwickSenior VP, CFO, Principal Financial Officer & Principal Accounting Officer | 2,94k | 0,00 | Derivative Exercise and Retained Stock | - | 5,40k | 119,24% |
| 2026-01-08 | Ms. Kathleen BorthwickSenior VP, CFO, Principal Financial Officer & Principal Accounting Officer | -2,06k | 38,02k | Derivative Exercise and Sale | 18,44 | 5,40k | - |
| 2025-09-11 | Lynx1 Capital Management LPUnternehmen | 32,01k | 223,73k | Kauf | 6,96 - 6,99 | 623,70k | 5,41% |
| 2025-07-22 | Lynx1 Capital Management LPUnternehmen | 128,85k | 733,83k | Kauf | 5,44 - 5,74 | 591,70k | 27,84% |
| 2025-07-21 | OrbiMed Advisors LLCUnternehmen | -104,05k | 587,82k | Verkauf | 5,51 - 5,78 | 132,47k | -43,99% |
| 2025-06-24 | OrbiMed Advisors LLCUnternehmen | -48,07k | 287,40k | Verkauf | 5,83 - 9,60 | 243,88k | -16,47% |
| 2025-06-27 | OrbiMed Advisors LLCUnternehmen | -7,14k | 62,18k | Verkauf | 6,80 - 9,60 | 296,18k | -2,35% |
| 2025-06-24 | OrbiMed Advisors LLCUnternehmen | -29,18k | 197,24k | Verkauf | 6,60 - 7,00 | 303,32k | -8,78% |